European Archives - Page 1162 of 1344 - European Medical Journal

Ophthalmology Cystinosis Forum Morning Session

This 1-day meeting was held at the Austria Trend Savoyen Hotel, Vienna, Austria. The morning session consisted of a series of presentations by experts in…

Ophthalmology Cystinosis Forum Afternoon Session

This 1-day meeting was held at the Austria Trend Savoyen Hotel, Vienna, Austria. The afternoon, chaired by Dr Hong Liang and Dr Rachel Bishop…

Nanoparticles Reactivate Dormant Viruses Within the Lungs

NANOPARTICLES produced by combustion engines may activate viruses that lie dormant in cells of the lung tissue, according to the results of a recently…

Potential Association Found Between Asthma and Childhood Obesity

A POSSIBLE association between obesity and asthma has been found according to the results of a new study; more specifically in early-life asthma which…

EMJ Dermatology 5 [Suppl 2] 2017

This expert masterclass, supported by an independent grant from OM/Vifor Pharma, brought together physicians specialising in vascular surgery…

EMJ Dermatology 5 [Suppl 3] 2017

Este seminario especializado financiado mediante una contribución independiente realizada por OM/Vifor Pharma reunió a facultativos especializados…

Insuficiencia venosa crónica: manejo y tratamiento

La EVC es una enfermedad preocupante que genera una carga significativa sobre los servicios sanitarios y la sociedad en general.

Chronic Venous Insufficiency: Management and Treatment

CVD is a very concerning condition which creates a significant burden on healthcare provision and wider society. Varicose veins are often the first sign of CVD.

A New Treatment Option for Malaria?

THE DISCOVERY of a protein that assists parasites in attacking human red blood cells could be used to develop more developed vaccines for the disease…

BIAL and Neurocrine Announce Exclusive North American Licensing Agreement for Opicapone

Porto, Portugal and San Diego, California, February 10, 2017 – BIAL and Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced that they have…